Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 100 shares at $20.00 ($2K) on 2018-04-30, disclosed to the SEC on 2018-05-02.
Scheduled sale ($2k) by Head of Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |